ATE179601T1 - Aufheben der resistenz von hiv-1 linien gegenüber zidovudine - Google Patents

Aufheben der resistenz von hiv-1 linien gegenüber zidovudine

Info

Publication number
ATE179601T1
ATE179601T1 AT94908308T AT94908308T ATE179601T1 AT E179601 T1 ATE179601 T1 AT E179601T1 AT 94908308 T AT94908308 T AT 94908308T AT 94908308 T AT94908308 T AT 94908308T AT E179601 T1 ATE179601 T1 AT E179601T1
Authority
AT
Austria
Prior art keywords
zidovudine
hiv
resistance
lines
viruses
Prior art date
Application number
AT94908308T
Other languages
English (en)
Inventor
Koenraad Jozef Lodewij Andries
Paulus Aloysius Maria Stoffels
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE179601T1 publication Critical patent/ATE179601T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Testing Or Measuring Of Semiconductors Or The Like (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Adornments (AREA)
  • Materials For Medical Uses (AREA)
AT94908308T 1993-02-22 1994-02-10 Aufheben der resistenz von hiv-1 linien gegenüber zidovudine ATE179601T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2128693A 1993-02-22 1993-02-22

Publications (1)

Publication Number Publication Date
ATE179601T1 true ATE179601T1 (de) 1999-05-15

Family

ID=21803366

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94908308T ATE179601T1 (de) 1993-02-22 1994-02-10 Aufheben der resistenz von hiv-1 linien gegenüber zidovudine

Country Status (11)

Country Link
EP (1) EP0684818B1 (de)
JP (1) JP2669937B2 (de)
CN (1) CN1118137A (de)
AT (1) ATE179601T1 (de)
AU (1) AU676021B2 (de)
CA (1) CA2155829A1 (de)
DE (1) DE69418312D1 (de)
OA (1) OA10226A (de)
SG (1) SG49651A1 (de)
WO (1) WO1994018963A1 (de)
ZA (1) ZA941178B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0872233A1 (de) * 1997-04-14 1998-10-21 Janssen Pharmaceutica N.V. Antiretrovirale Arzneimittel mit verbesserter Bioverfügbarkeit
TR200200763T2 (tr) 1999-09-24 2003-09-22 Janssen Pharmaceutica N.V. Antiviral bileşimler

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68900926D1 (de) * 1988-09-28 1992-04-09 Sigma Tau Ind Farmaceuti Pharmazeutische zubereitung, die zidovudin und inosiplex oder bestandteile davon enthaelt, fuer die behandlung von aids-verwandten syndromen.
IE75693B1 (en) * 1990-07-10 1997-09-10 Janssen Pharmaceutica Nv HIV-inhibiting benzeneacetamide derivatives
IL99843A0 (en) * 1990-11-01 1992-08-18 Merck & Co Inc Synergistic combination of hiv reverse transcriptase inhibitors

Also Published As

Publication number Publication date
EP0684818A1 (de) 1995-12-06
ZA941178B (en) 1995-08-21
WO1994018963A1 (en) 1994-09-01
OA10226A (en) 1997-10-07
DE69418312D1 (de) 1999-06-10
JPH08505642A (ja) 1996-06-18
CN1118137A (zh) 1996-03-06
AU676021B2 (en) 1997-02-27
EP0684818B1 (de) 1999-05-06
AU6139894A (en) 1994-09-14
SG49651A1 (en) 1998-06-15
JP2669937B2 (ja) 1997-10-29
CA2155829A1 (en) 1994-09-01

Similar Documents

Publication Publication Date Title
EA199700331A1 (ru) Тгф-содержащие сульфонамидные ингибиторы аспартил-протеазы
NO950670L (no) N-(alkanoylamino-2-hydroksypropyl)sulfonamider som er nyttige som retrovirale proteaseinhibitorer
NO20006405L (no) Sulfonamidinhibitorer for aspartylprotease
TR199701194T1 (xx) Aspartil proteaz�n oksijenlenmi� heterosikl i�eren s�lfonamit inhibit�rleri.
NO20004027L (no) Fluorinerte ionomerer og deres anvendelser
ATE315667T1 (de) Amplifizierung und detektion von hiv-1 und/oder hiv-2
BR0011745A (pt) Inibidores de aspartil protease
MY142901A (en) Novel sulfonamide inhibitors of aspartyl protease
ES2040231T3 (es) Composiciones medicamentosas estables.
ES2155887T3 (es) Produccion de pentafluoroetano.
ATE179601T1 (de) Aufheben der resistenz von hiv-1 linien gegenüber zidovudine
EA199800661A1 (ru) Ингибиторы аспартильных протеаз
KR890701738A (ko) 인체면역결핍 비루스 특이성 단백질분해효소와 이들의 합성 및 원형재현 방법
ATE272126T1 (de) Nachweis von retroviralen untertypen auf der basis der spezifischen sequenzen der hülle
ES2000908A6 (es) Procedimiento para la fabricacion de nuevos derivados de alquilmercaptofenil-1,3,4-oxadiazol
NO873902D0 (no) Fremgangsmaate for aa forbedre overflaters evne til aa motstaa isdannelse eller aa fjerne allerede dannet is.
ATE401573T1 (de) Tsg101 als inhibitor der hiv-produktion
DE69614127D1 (de) Eine familie von verbindungen mit entzündungshemmender und antiviraler aktivität und deren zusammensetzungen alleine oder in verbindung mit inhibitoren der reversen transcriptase zur inhibierung, vermeidung oder eliminierung viraler replikation und methoden zu ihrer verwendung
ATA181493A (de) Elektrolysezelle
ATE148105T1 (de) Succinoylaminohydroxyäthylaminosulfamidsäureder vate und ihre verwendung als retrovirale proteasehemmer
FI820292L (fi) Nya bis- och polydisulfider vilka har immunostimulerande aktivitet
FR2621816B1 (fr) Application antivirale des ologonucleotides
ES544873A0 (es) Un catalizador de polimerizacion y su procedimiento de fa- bricacion
KR960031593A (ko) 타타르산을 이용한 수두 바이러스의 활성 증진 방법
FR2399453A1 (fr) Polyester-imide a base d'adamantane et procede pour sa fabrication

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties